[Pseudohypoaldosteronism type I].
Kaneko K.
Nihon Jinzo Gakkai Shi. 2011;53(2):150-4.
[Neonatal systemic pseudohypoaldosteronism type I].
Cao XC, Chen YY, Zhang K, Zhang XJ, Yang L, Li ZH.
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):774-778. doi: 10.7499/j.issn.1008-8830.2305011.
Mechanisms of type I and type II pseudohypoaldosteronism.
Furgeson SB, Linas S.
J Am Soc Nephrol. 2010 Nov;21(11):1842-5. doi: 10.1681/ASN.2010050457. Epub 2010 Sep 9.
[Pseudohypoaldosteronism type I].
Fila M, Amouroux C, Morin D.
Arch Pediatr. 2015 May;22(5 Suppl 1):43-5. doi: 10.1016/S0929-693X(15)30023-3.
Pseudohypoaldosteronism type-I: a rare cause of hyperkalemia in neonates.
Bangash AS, Ali NF, Sami S, Iqbal M.
J Pak Med Assoc. 2014 Apr;64(4):484-6.
Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
Hanukoglu A.
J Clin Endocrinol Metab. 1991 Nov;73(5):936-44. doi: 10.1210/jcem-73-5-936.
[Pseudohypoaldosteronism type I].
Endoh A.
Nihon Rinsho. 2006 May 28;Suppl 1:665-8.
Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengchareun S, Lombès M, Zennaro MC.
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):119-25. doi: 10.1016/j.mce.2003.10.017.
A late diagnosis of Pseudohypoaldosteronism type I in an infant with hypoplastic left heart syndrome presenting with failure to thrive.
McVadon DH, Costello JM, Twombley KE, Zyblewski SC.
Cardiol Young. 2022 Mar;32(3):491-493. doi: 10.1017/S1047951121003127. Epub 2021 Aug 12.
[Pseudohypoaldosteronism (type I)].
Ogino Y, Kinouchi T.
Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):650-2.
